Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

A20 and Tumor Immune Responses

$5.53M USD

Funder NATIONAL CANCER INSTITUTE
Recipient Organization University of California, San Francisco
Country United States
Start Date Aug 01, 2024
End Date Jul 31, 2029
Duration 1,825 days
Number of Grantees 1
Roles Principal Investigator
Data Source NIH (US)
Grant ID 10990973
Grant Description

Abstract Immunosuppressive and homeostatic mechanisms prevent immune cells and tissues from eliminating solid tumors, limiting the efficacy of anti-tumor immunity. Precise dissection of these homeostatic mechanisms can lead to better understanding of how tumors persist and grow within tissues. Our prior studies demonstrate that

the A20 protein is a potent regulator of immune homeostasis, regulating both pro-inflammatory and cell death signals. Our recent preliminary data reveal that A20 is highly expressed in tumor microenvironments and that one specific biochemical motif of this protein restrains both acute and anamnestic antitumor immunity. This

proposal will dissect the cellular and molecular pathways by which A20 regulates anti-tumor immunity.

All Grantees

University of California, San Francisco

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant